The closing price of Healthcare Realty Trust Inc (NYSE: HR) was $13.28 for the day, up 1.07% from the previous closing price of $13.14. In other words, the price has increased by $+0.14 from its previous closing price. On the day, 3297620 shares were traded.
Ratios:
Our analysis of HR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 196.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.13. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on February 20, 2024, Downgraded its rating to Neutral and sets its target price to $15 from $19 previously.
On February 20, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $19 to $15.
On January 30, 2024, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $18.Deutsche Bank initiated its Hold rating on January 30, 2024, with a $18 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 when Hull Robert E sold 25,394 shares for $17.01 per share. The transaction valued at 431,952 led to the insider holds 169,257 shares of the business.
Wilson Julie F. sold 4,100 shares of HR for $70,930 on Dec 15. The EVP – Operations now owns 116,233 shares after completing the transaction at $17.30 per share. On Aug 16, another insider, SINGLETON JOHN KNOX, who serves as the Director of the company, bought 31,500 shares for $17.11 each. As a result, the insider paid 538,965 and bolstered with 50,582 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HR now has a Market Capitalization of 5.06B and an Enterprise Value of 10.34B. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.77 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 7.69 whereas that against EBITDA is 13.92.
Stock Price History:
Over the past 52 weeks, HR has reached a high of $20.32, while it has fallen to a 52-week low of $13.06. The 50-Day Moving Average of the stock is 16.31, while the 200-Day Moving Average is calculated to be 16.89.
Shares Statistics:
HR traded an average of 3.58M shares per day over the past three months and 5.17M shares per day over the past ten days. A total of 380.96M shares are outstanding, with a floating share count of 379.01M. Insiders hold about 0.57% of the company’s shares, while institutions hold 106.28% stake in the company. Shares short for HR as of Jan 31, 2024 were 8.8M with a Short Ratio of 2.45, compared to 10.01M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.31% and a Short% of Float of 3.87%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.24, HR has a forward annual dividend rate of 1.55. Against a Trailing Annual Dividend Yield of 9.44%, it implies a Forward Annual Dividend Yield of 9.34%. The stock’s 5-year Average Dividend Yield is 4.50.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.14, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.43 and -$0.53 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.45, with 3 analysts recommending between -$0.43 and -$0.47.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $328.9M to a low estimate of $326.5M. As of the current estimate, Healthcare Realty Trust Inc’s year-ago sales were $329M, an estimated decrease of -0.40% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $329.75M, a decrease of -0.60% less than the figure of -$0.40% in the same quarter last year. There is a high estimate of $331.3M for the next quarter, whereas the lowest estimate is $328.2M.
A total of 4 analysts have provided revenue estimates for HR’s current fiscal year. The highest revenue estimate was $1.4B, while the lowest revenue estimate was $1.32B, resulting in an average revenue estimate of $1.35B. In the same quarter a year ago, actual revenue was $1.34B, up 0.30% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $1.37B in the next fiscal year. The high estimate is $1.37B and the low estimate is $1.36B. The average revenue growth estimate for next year is up 1.50% from the average revenue estimate for this year.
